Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,438 | 63 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HealthCare | $687.56 | 21 | $0 (2023) |
| Amgen Inc. | $395.60 | 5 | $0 (2024) |
| Telix Pharmaceuticals | $323.86 | 10 | $0 (2024) |
| Horizon Therapeutics plc | $304.18 | 4 | $0 (2023) |
| Progenics Pharmaceuticals, Inc. | $277.31 | 4 | $0 (2022) |
| Siemens Medical Solutions USA, Inc. | $272.58 | 4 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $242.55 | 2 | $0 (2022) |
| Eisai Inc. | $234.90 | 2 | $0 (2024) |
| Horizon Pharma plc | $124.06 | 1 | $0 (2017) |
| AbbVie Inc. | $115.33 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.13 | 4 | Eisai Inc. ($110.00) |
| 2023 | $570.54 | 16 | Telix Pharmaceuticals ($298.06) |
| 2022 | $836.24 | 15 | GE HealthCare ($248.99) |
| 2021 | $792.50 | 17 | GE HEALTHCARE ($292.09) |
| 2018 | $584.10 | 7 | Amgen Inc. ($342.27) |
| 2017 | $465.04 | 4 | Eisai Inc. ($124.90) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 08/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $110.00 | General |
| Category: Neurology | ||||||
| 12/07/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $95.64 | General |
| Category: KRYSTEXXA | ||||||
| 12/06/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/08/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| 10/04/2023 | Cleerly, Inc. | Cleerly Labs (Device) | Food and Beverage | In-kind items and services | $16.31 | General |
| 09/19/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/16/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 08/09/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $42.05 | General |
| 08/09/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $42.05 | General |
| 08/09/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $42.05 | General |
| 08/09/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/26/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/13/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/10/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/28/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/08/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 04/11/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: KRYSTEXXA | ||||||
| 11/03/2022 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $82.35 | General |
| 10/06/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $23.91 | General |
| 10/05/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $16.02 | General |
| 08/24/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $56.60 | General |
| 08/10/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,402 | 87,293 | $2.8M | $487,732 |
| 2022 | 33 | 3,521 | 81,353 | $2.9M | $538,293 |
| 2021 | 33 | 3,018 | 69,192 | $2.5M | $480,561 |
| 2020 | 25 | 2,325 | 47,605 | $1.9M | $364,409 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 229 | 296 | $241,285 | $62,121 | 25.7% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 227 | 301 | $196,250 | $41,803 | 21.3% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 132 | 171 | $227,800 | $40,382 | 17.7% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Office | 2023 | 100 | 143 | $150,345 | $39,737 | 26.4% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 167 | 226 | $185,932 | $33,885 | 18.2% |
| 73221 | Mri scan of arm joint without contrast | Office | 2023 | 179 | 236 | $148,679 | $31,297 | 21.1% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 257 | 342 | $168,385 | $29,428 | 17.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 117 | 145 | $161,796 | $27,871 | 17.2% |
| 73700 | Ct scan of leg without contrast | Office | 2023 | 216 | 317 | $158,270 | $27,517 | 17.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 163 | 216 | $109,428 | $25,929 | 23.7% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2023 | 73 | 97 | $123,580 | $20,906 | 16.9% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 146 | 190 | $60,435 | $14,662 | 24.3% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 49 | 63 | $56,386 | $14,235 | 25.2% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 72 | 93 | $59,124 | $10,300 | 17.4% |
| 73200 | Ct scan of arm without contrast | Office | 2023 | 55 | 92 | $43,435 | $8,504 | 19.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 604 | 64,725 | $258,900 | $7,439 | 2.9% |
| 74181 | Mri scan of abdomen without contrast | Office | 2023 | 45 | 55 | $51,700 | $6,764 | 13.1% |
| 77049 | Mri scan of both breasts | Office | 2023 | 21 | 27 | $27,510 | $6,180 | 22.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 37 | 47 | $23,125 | $5,846 | 25.3% |
| 73718 | Mri scan of leg without contrast | Office | 2023 | 32 | 35 | $39,930 | $5,516 | 13.8% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 35 | 46 | $29,260 | $5,366 | 18.3% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 234 | 19,176 | $153,408 | $4,996 | 3.3% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 58 | 63 | $13,725 | $3,999 | 29.1% |
| 76391 | Mri and low frequency vibrations for measuring tissue stiffness | Office | 2023 | 24 | 28 | $17,901 | $3,811 | 21.3% |
| 72195 | Mri scan of pelvis without contrast | Office | 2023 | 20 | 21 | $24,800 | $3,780 | 15.2% |
About Dr. Arvinder Uppal, M.D
Dr. Arvinder Uppal, M.D is a Diagnostic Radiology healthcare provider based in Columbia, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073585261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arvinder Uppal, M.D has received a total of $3,438 in payments from pharmaceutical and medical device companies, with $189.13 received in 2024. These payments were reported across 63 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,438).
As a Medicare-enrolled provider, Uppal has provided services to 12,266 Medicare beneficiaries, totaling 285,443 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Columbia, MD
- Active Since 02/02/2006
- Last Updated 10/11/2016
- Taxonomy Code 2085R0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073585261
Products in Payments
- ILLUCCIX (Drug) $323.86
- NURTEC ODT (Drug) $313.16
- PYLARIFY (Drug) $277.31
- KRYSTEXXA (Biological) $275.16
- MAGNETOM Vida 3T (Device) $135.96
- Fycompa (Drug) $124.90
- KRYSTEXXA (Drug) $124.06
- Aimovig (Biological) $120.90
- MAGNETOM Vida (Device) $117.14
- UBRELVY (Drug) $115.33
- Leqembi (Drug) $110.00
- LYRICA (Drug) $108.33
- JARDIANCE (Drug) $107.75
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) $58.67
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM CONSUMABLES (Device) $36.75
- AUSTEDO (Drug) $33.30
- Cerianna (Drug) $19.48
- Axumin (Drug) $17.45
- Cleerly Labs (Device) $16.31
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $10.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Columbia
Dr. Talissa Altes, M.d, M.D
Diagnostic Radiology — Payments: $205,860
Kavi Devulapalli, Md, MD
Diagnostic Radiology — Payments: $48,732
Wesley Conwell, Md, MD
Diagnostic Radiology — Payments: $11,751
Dr. James Butler, Md, MD
Diagnostic Radiology — Payments: $3,799
Dr. Kelli Moore, M.d, M.D
Diagnostic Radiology — Payments: $1,882
Megha Garg, M.d, M.D
Diagnostic Radiology — Payments: $1,807